David Wonderling

researcher

David Wonderling is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0003-0315-6273

P734family nameWonderlingQ37034507
WonderlingQ37034507
WonderlingQ37034507
P735given nameDavidQ18057751
DavidQ18057751
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q89240984A Cost-Effectiveness Analysis Of Interventions For Symptomatic Varicose Veins
Q38598452A Cost-effectiveness Analysis of Surgery, Endothermal Ablation, Ultrasound-guided Foam Sclerotherapy and Compression Stockings for Symptomatic Varicose Veins
Q36623431A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics
Q36695547A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.
Q43252591Acupuncture in mainstream health care.
Q35939934Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis.
Q39070719Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis.
Q34563933Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials
Q28187932Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening
Q73282223Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation
Q37268515Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care
Q24528552Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia
Q94322964Cost effectiveness of health checks
Q34210937Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study
Q36598627Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.
Q37740803Developing guidelines for venous thromboembolism for The National Institute for Clinical Excellence: involvement of the orthopaedic surgical panel.
Q47915626Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale.
Q87439389Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance
Q77811930Economic analysis of a pragmatic randomised trial of home visits by a nurse to elderly people with hypertension in Mexico
Q35064567Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.
Q80521393Laparoscopic donor nephrectomy: is it cost effective? Perspective from health economists
Q39260883Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis.
Q51028860National Clinical Guideline Centre cost-effectiveness assessment for the National Institute for Health and Clinical Excellence.
Q46873751Nice Clinical Guideline on Managing Faecal Incontinence: Evidence of the Effectiveness and Cost-Effectiveness of Surgical Interventions
Q51839068Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.
Q41585693Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.
Q37964152The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis.
Q45928983Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.
Q27003961Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses
Q30547712Trial-based cost-effectiveness analysis comparing surgical and endoscopic drainage in patients with obstructive chronic pancreatitis.
Q36598609What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses.